journal article·2010-05-25

Oxidized Ultrashort Nanotubes as Carbon Scaffolds for the Construction of Cell-Penetrating NF-κB Decoy Molecules

Rita Crinelli, Elisa Carloni, Michele Menotta, Elisa Giacomini, Marzia Bianchi, Gianluca Ambrosi, Luca Giorgi, Mauro Magnani

ACS Nano· Volume 4· Issue 5
Publisher page

Abstract

Oligonucleotide (ODN) decoys are synthetic ODNs containing the DNA binding sequence of a transcription factor. When delivered to cells, these molecules can compete with endogenous sequences for binding the transcription factor, thus inhibiting its ability to activate the expression of target genes. Modulation of gene expression by decoy ODNs against nuclear factor-kappaB (NF-kappaB), a transcription factor regulating many genes involved in immunity, has been achieved in a variety of immune/inflammatory disorders. However, the successful use of transcription factor decoys depends on an efficient means to bring the synthetic DNA to target cells. It is known that single-walled carbon nanotubes (SWCNTs), under certain conditions, are able to cross the cell membrane. Thus, we have evaluated the possibility to functionalize SWCNTs with decoy ODNs against NF-kappaB in order to improve their intracellular delivery. To couple ODNs to CNTs, we have exploited the carbodiimide chemistry which allows covalent binding of amino-modified ODNs to carboxyl groups introduced onto SWCNTs through oxidation. The effective binding of ODNs to nanotubes has been demonstrated by a combination of microscopic, spectroscopic, and electrophoretic techniques. The uptake and subcellular distribution of ODN decoys bound to SWCNTs was analyzed by fluorescence microscopy. ODNs were internalized into macrophages and accumulated in the cytosol. Moreover, no cytotoxicity associated with SWCNT administration was observed. Finally, NF-kappaB-dependent gene expression was significantly reduced in cells receiving nanomolar concentrations of SWCNT-NF-kappaB decoys compared to cells receiving SWCNTs or SWCNTs functionalized with a nonspecific ODN sequence, demonstrating both efficacy and specificity of the approach.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomolecular Sciences, Biochemistry and Molecular Biology Section

Institute of Chemical Sciences, University of Urbino “Carlo Bo”, 61029 Urbino (PU), Italy

References (55)

Show source-provided references
1. Patil S. D. · AAPS J. · 2005 · 7 · E6110.1208/aapsj070109 ↗
2. Tomita N. · Curr. Drug Targets · 2003 · 4 · 60310.2174/1389450033490803 ↗
3. Mann M. J. · J. Clin. Invest. · 2000 · 106 · 107110.1172/JCI11459 ↗
4. Igawa K. · Br. J. Dermatol. · 2009 · 160 · 112410.1111/j.1365-2133.2009.09070.x ↗
5. Sen M. · Cancer Chemother. Pharmacol. · 2009 · 63 · 98310.1007/s00280-008-0823-6 ↗
6. Baldwin A. S. · J. Clin. Invest. · 2001 · 107 · 310.1172/JCI11891 ↗
7. Isomura I. · Microbiol. Immunol. · 2006 · 50 · 55910.1111/j.1348-0421.2006.tb03827.x ↗
8. Higuchi Y. · J. Controlled Release · 2005 · 107 · 37310.1016/j.jconrel.2005.07.004 ↗
9. El-Andaloussi S. · J. Controlled Release · 2005 · 110 · 18910.1016/j.jconrel.2005.09.012 ↗
10. Gao H. · Mol. Pharmacol. · 2006 · 70 · 162110.1124/mol.106.024273 ↗
11. De Rosa G. · J. Pharm. Biopharm. · 2008 · 70 · 710.1016/j.ejpb.2008.03.012 ↗
12. Tomita N. · J. Gene Med. · 2002 · 4 · 52710.1002/jgm.300 ↗
13. Ehsan A. · J. Thorac. Cardiovasc. Surg. · 2001 · 121 · 71410.1067/mtc.2001.111204 ↗
14. Yang W. · Nanotechnology · 2007
15. Wu Y. · ACS Nano · 2008 · 2 · 202310.1021/nn800325a ↗
16. Liu Z. · Angew. Chem., Int. Ed. · 2001 · 46 · 202310.1002/anie.200604295 ↗
17. Kam N. W. · J. Am. Chem. Soc. · 2005 · 127 · 1249210.1021/ja053962k ↗
18. Zhang Z. · Clin. Cancer Res. · 2006 · 12 · 493310.1158/1078-0432.CCR-05-2831 ↗
19. Cui D. · J. Nanosci. Nanotechnol. · 2007 · 7 · 163910.1166/jnn.2007.348 ↗
20. Crinelli R. · Nucleic Acids Res. · 2002 · 30 · 243510.1093/nar/30.11.2435 ↗
21. Berkowitz B. · J. Biol. Chem. · 2002 · 277 · 2469410.1074/jbc.M200006200 ↗
22. Zheng M. · Science · 2003 · 302 · 154510.1126/science.1091911 ↗
23. Gigliotti B. · Nano Lett. · 2006 · 6 · 15910.1021/nl0518775 ↗
24. Zhao X. · J. Am. Chem. Soc. · 2007 · 129 · 1043810.1021/ja071844m ↗
25. Singh R. · J. Am. Chem. Soc. · 2005 · 127 · 438810.1021/ja0441561 ↗
26. Hazani M. · Nano Lett. · 2003 · 3 · 15310.1021/nl025874t ↗
27. Gao Y. · Bioconjugate Chem. · 2008 · 19 · 194510.1021/bc800051c ↗
28. Chen Z. · J. Am. Chem. Soc. · 2006 · 128 · 1056810.1021/ja063283p ↗
29. Forrest A. G. · J. Phys. Chem. C · 2007 · 111 · 1079210.1021/jp0716839 ↗
30. Kim J. M. · Anal. Chim. Acta · 2004 · 525 · 15110.1016/j.aca.2004.08.034 ↗
31. Avdoshenko S. M. · Rapid Commun. Mass Spectrom. · 2008 · 22 · 137210.1002/rcm.3508 ↗
32. Lukacs G. L. · J. Biol. Chem. · 2000 · 275 · 162510.1074/jbc.275.3.1625 ↗
33. Koki A. · Adv. Exp. Med. Biol. · 2002 · 507 · 17710.1007/978-1-4615-0193-0_28 ↗
34. Pease J. E. · Am J. Respir. Med. · 2002 · 1 · 1910.1007/BF03257159 ↗
35. Tan Z. Y. · Int. J. Biochem. Cell Biol. · 2009 · 41 · 73310.1016/j.biocel.2008.04.027 ↗
36. Saccani S. · J. Exp. Med. · 2001 · 193 · 135110.1084/jem.193.12.1351 ↗
37. Nelson D. E. · Science · 2004 · 306 · 70410.1126/science.1099962 ↗
38. Firme C. P. · Nanomedicine · 2010 · 6 · 24510.1016/j.nano.2009.07.003 ↗
39. Pacurari M. · Environ. Health. Perspect. · 2008 · 116 · 121110.1289/ehp.10924 ↗
40. Porter A. E. · Nat. Nanotechnol. · 2007 · 11 · 71310.1038/nnano.2007.347 ↗
41. Kolosnjaj-Tabi J. · ACS Nano · 2010 · 4 · 148110.1021/nn901573w ↗
42. Porter A. E. · ACS Nano · 2009 · 3 · 148510.1021/nn900416z ↗
43. Saxena R. K. · Nanotoxicology · 2007 · 1 · 29110.1080/17435390701803110 ↗
44. Kam N. W. · J. Am. Chem. Soc. · 2005 · 127 · 602110.1021/ja050062v ↗
45. Nicholson D. W. · Nature · 1995 · 376 · 3710.1038/376037a0 ↗
46. Mahmood M. · J. Appl. Toxicol. · 2010 · 30 · 7410.1002/jat.1475 ↗
47. Walker V. G. · Toxicol. Appl. Pharmacol. · 2009 · 236 · 31910.1016/j.taap.2009.02.018 ↗
48. Beutler E. · 1984 · 65
49. Liu H. · J. Exp. Med. · 2001 · 194 · 11310.1084/jem.194.2.113 ↗
50. Raffa V. · Carbon · 2008 · 46 · 160010.1016/j.carbon.2008.06.053 ↗
51. Ma Y. · Curr. Pharm. Des. · 2005 · 11 · 56910.2174/1381612053381927 ↗
52. Hu H. · Chem. Phys. Lett. · 2001 · 345 · 2510.1016/S0009-2614(01)00851-X ↗
53. Crinelli R. · Nucleic Acids Res. · 2004 · 32 · 187410.1093/nar/gkh503 ↗
54. Livak K. J. · Methods · 2001 · 25 · 40210.1006/meth.2001.1262 ↗
55. Wörle-Knirsch J. M. · Nano Lett. · 2006 · 6 · 126110.1021/nl060177c ↗